1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. SHARON BIO-MEDICINE LTD.
Sharon Bio-Medicine Ltd. BSE: 532908


Board Meetings - Sharon Bio-Medicine Ltd.

The latest board meeting for Sharon Bio-Medicine Ltd. took place on 30 May 2023, for the purpose of Audited Results

Ex-date Purpose Notes
30 May 2023 Audited Results -
10 Feb 2023 Quarterly Results -
11 Nov 2022 Quarterly Results -
12 Aug 2022 Quarterly Results -
17 May 2022 Audited Results -
07 Feb 2022 Quarterly Results -
03 Nov 2021 Quarterly Results -
13 Aug 2021 Quarterly Results -
23 Jun 2021 Audited Results -
12 Feb 2021 Quarterly Results -
11 Nov 2020 Quarterly Results -
11 Sep 2020 Quarterly Results (Revised)
26 Jun 2020 Audited Results -
12 Feb 2020 Quarterly Results -
14 Nov 2019 Quarterly Results -
14 Aug 2019 Quarterly Results -
24 May 2019 Audited Results -
14 Feb 2019 Quarterly Results -
14 Nov 2018 Quarterly Results -
14 Aug 2018 Unaudited Financial Results -
30 May 2018 Audited Results -
22 Feb 2018 Quarterly Results -
08 Dec 2017 Audited Results -
13 Feb 2017 Quarterly Results -
10 Nov 2016 Quarterly Results -
11 Aug 2016 Quarterly Results & Others To consider appointment of Scrutinizer to oversee the e-voting process of the Company at the 27th Annual General Meeting;
21 Jun 2016 Others Inter alia, to consider and discuss the overall financial viability of the Company.
30 May 2016 Audited Results -
12 Feb 2016 Quarterly Results -
12 Jan 2016 Resignation of Directors & Others Closure of the subsidiary Company M/s Yusur International FZE.
10 Nov 2015 Quarterly Results -
29 Aug 2015 Audited Results -
10 Jun 2015 Allotment of Equity shares -
14 May 2015 Quarterly Results -
30 Mar 2015 Allotment of Equity shares For allotment of equity shares on account of conversion of warrants.
17 Mar 2015 Others Due to fire in one of the plant of the Company in 2014, and non availability of the working capital to Company.
14 Feb 2015 Quarterly Results -
21 Nov 2014 Dividend & Others Recommendation of dividend on 105569000 equity shares of Rs.2/ each fully paid up for the year ended 30"' June, 2014, subject to approval of the members at the ensuing Annual General Meeting.
13 Nov 2014 Quarterly Results -
20 Oct 2014 Preferential issue For the allotment of 1,61,11,000 warrants on preferential basis.
28 Aug 2014 Audited Results for the financial year ended 30th June, 2014.
02 Jul 2014 To Consider Pricing of Warrants To consider pricing of warrants to be issued to promoter Group on preferential basis for which Postal Ballot Notice
10 Jun 2014 Preferential issue To consider issue of warrants / shares to Promoter group on Preferential basis.
15 May 2014 Quarterly Results -
24 Feb 2014 Allotment of Bonus Shares inter alia, for allotment of Bonus shares to the shareholders.
08 Feb 2014 Quarterly Results -
14 Jan 2014 Stock Split & Bonus issue -
26 Nov 2013 To approve the restructuring plan -
12 Nov 2013 Quarterly Results -
29 Aug 2013 Quarterly Results -
15 May 2013 Quarterly Results -
14 Feb 2013 Quarterly Results -
12 Nov 2012 Quarterly Results -
22 Oct 2012 Audited Results & Dividend for the year ended 30/6/2012.
14 Aug 2012 Quarterly Results -
03 May 2012 Quarterly Results -
14 Feb 2012 Quarterly Results -
03 Nov 2011 Quarterly Results -
24 Oct 2011 Audited Results & Dividend -
25 Jul 2011 Quarterly Results -
11 May 2011 Quarterly Results -
29 Jan 2011 Quarterly Results -
04 Dec 2010 Audited Results & Dividend To decide and fix date and venue of Annual General Meeting, Book Closure Date.
30 Oct 2010 Quarterly Results -
12 Aug 2010 Quarterly Results -
27 Apr 2010 Quarterly Results -
30 Jan 2010 Quarterly Results -
02 Dec 2009 Audited Results & Dividend -
27 Oct 2009 Quarterly Results -
28 Jul 2009 Quarterly Results -
30 Apr 2009 Quarterly Results -
31 Jan 2009 Quarterly Results -
02 Dec 2008 Audited Results, Dividend & Others To decide and fix the date and venue of the Annual General Meeting and the Book Closure date.
31 Oct 2008 Quarterly Results -
28 Jul 2008 Quarterly Results -
27 May 2008 Merger / Amalgamation -
29 Apr 2008 Quarterly Results -
05 Mar 2008 To consider merger of WoS To consider a proposal of merger of M/s. Stonewood Cem-Fab (India) Pvt Ltd, Wholly owned subsidiary of the Company.
29 Jan 2008 Quarterly Results -
06 Dec 2007 Audited Results & Dividend -
29 Oct 2007 Quarterly Results -
25 Jul 2007 Quarterly Results & Dividend -
23 Apr 2007 Quarterly Results -
09 Apr 2007 To consider issue of equity shares To consider for issue of 1,50,000 Equity shares and 3,75,000 warrants on preferential basis in terms of Special Resolutions passed in the Extra Ordinary General Meeting held on March 15, 2007.
29 Mar 2007 Preferential Offer Adjourned.......
15 Feb 2007 Preferential Offer To consider issue of 1,50,000 Equity shares of Rs 10/- each at Price of Rs 300/- per share to M/s. Pharmtak Ltd, Mauritius & 3,75,000 warrants to M/s. Asis Industries Ltd. on preferential basis.
23 Jan 2007 Quarterly Results -
15 Nov 2006 Appointment of Director To consider an appointment of Director of the Company.
18 Oct 2006 Quarterly Results -
07 Sep 2006 Accounts & Dividend -
09 Jun 2006 To consider GDR/ADR Issue To consider and approve issue of Global Depository Receipts (GDRs) / American Depository Receipts (ADRs) or FCCBs or Equity Shares by the Company.
14 Apr 2006 Quarterly Results & Others Inter alia, to consider the following: 1. Follow on Public Offer of Equity Shares of the Company. 2. Increase in Authorised Capital of the Company.
16 Mar 2006 Appointment of Independent Director -
25 Jan 2006 Quarterly Results & Expansion To set up USFDA based plant at Dehradun, Uttaranchal on Oncology Injectibles at the cost of approx. Rs 240 million.
29 Nov 2005 Accounts, Stock Split & Others Voluntary Delisting of Shares (Accounts & Stock split - Not considered)
25 Oct 2005 Quarterly Results -
29 Jul 2005 Quarterly Results -
07 Jul 2005 Acquisition of land at Dehradun Board has finalized the 5 Acres of Land at Dehradun having worth around Rs 150 lacs in which the Company will be putting as Per WHO.
29 Jan 2005 Quarterly Results -